Date filed
14 May 2021
Countries of harm
Current status


On 14 May 2021, Iranian Center for International Criminal Law filed a specific instance against Mölnlycke Health Care at the Swedish NCP. The complaint concerns the human rights impacts of the decision of Mölnlycke Health Care to stop selling its medical products in Iran due to US sanctions against Iran. The complainants allege that Mölnlycke breached its due diligence and human rights obligations under the OECD Guidelines when it chose to discontinue sale of an essential health care product without attempting to prevent or mitigate foreseeable impacts to patients relying on Mölnlycke as the sole provider of the product in Iran. As a result, children suffering from epidermolysis bullosa (EB), a rare and deadly genetic disease that causes blisters, sores and wounds to the skin, have experienced serious injury and even death. Complainants are seeking mediation from the NCP to address the irresponsible disengagement of Mölnlycke and ensure the company both assures the provision of this essential health product in Iran and provides the victims with prompt reparation.

Relevant OECD Guidelines

More details